Cresco Labs Inc
To Buy or Not to Buy the Dip on Cresco Labs (CRLBF) Stock
Cresco Labs Stock Is a Buy Due to Strong Growth Prospects
Cresco Labs Gets Another ‘Buy’ Rating
Yesterday, Eight Capital initiated coverage on Cresco Labs (CRLBF) with a “buy” rating.
Acreage Holdings Posts Disappointing Results in Q1 2020
Acreage Holdings’ first-quarter pro forma revenue grew 65% YoY (year-over-year) to $37.6 million. The revenue beat analysts’ estimates of $34.9 million.
How Analysts View Cresco Labs before Its Q1 Release
Cresco Labs (CRLBF) is slated to release its first-quarter earnings on May 29.
Illinois’ Cannabis Sales Soared in June: Which Stocks Will Benefit?
Cannabis sales have been soaring in all of the US states that classified it as an “essential item” amid the pandemic. Illinois has seen tremendous growth.
Cresco Labs’ Q1 Earnings: Dazzling Growth amid COVID-19
Cresco Labs reported its results for the first quarter of fiscal 2020 on May 28. The stock declined 4.2% and closed at $4.8 on the OTC markets yesterday.
Canopy Growth Might Impress Investors with Its Q4 Earnings
Canopy Growth (NYSE:CGC)(TSE:WEED) will likely report its results for the fourth quarter of fiscal 2020 on May 29 before the market opens.
Marijuana Legalization in South Dakota Lies with Voters Now
Marijuana legalization in South Dakota could see daylight in 2020. The state passed measures to legalize both recreational and medical marijuana.
Did MedMen’s Q3 Earnings Start a Path to Recovery?
MedMen released its results for the third quarter of fiscal 2020 on May 27. The stock declined 4.0% and closed at $0.35 on the OTC markets.
Why Origin House’s Acquisition Is Vital for Cresco Labs
On December 31, 2019, Origin House (OH) announced that its shareholders had approved Cresco Labs’ (CRLBF) acquisition plan.
Cresco Labs Announces Expansion in Ohio before Q1 Earnings
Cresco Labs (OTCMKTS:CRLBF) will likely report its financial results for the first quarter of fiscal 2020 on May 28 after the market closes.
Curaleaf Holdings Completes Curaleaf NJ’s Acquisition
Curaleaf Holdings (OTCMKTS:CURLF) continued its expansion by completing the acquisition of Curaleaf NJ, which owns a medical license in New Jersey.
Marijuana Legalization Still Has a Chance in Idaho
Marijuana legalization in Idaho had to bear the brunt of the coronavirus pandemic. The lockdown forced the state to suspend its medical marijuana campaign.
Curaleaf Plans a Nationwide Expansion of ‘Select’ Brand
Curaleaf (OTCMKTS:CURLF) acquired a “Select” brand in February 2020. The company received positive feedback in medical and adult-use markets.
Green Thumb Keeps Expanding Its Operations in Las Vegas
On June 27, Green Thumb Industries (OTCMKTS:GTBIF) opened its fifth Essence brand store in Las Vegas and its 48th retail store in the US.
Canopy Growth Revised Its Agreement with Acreage Holdings
Canopy Growth entered into an agreement with US-based cannabis company Acreage Holdings last year. However, the company announced some changes.
Could Acreage Holdings’ Q1 Earnings Boost Its Stock?
Acreage Holdings (OTCMKTS:ACRGF) will likely report its results for the first quarter of fiscal 2020 on Friday before the market opens.
Cannabis Market in Illinois Grows, Challenges Remain
The growth in Illinois’s cannabis market is evident from its record sales in May. The state sold adult-use cannabis worth $44.3 million in May.
MedMen’s Medical Marijuana Dispensary License Revoked in Virginia
The Virginia Board of Pharmacy voted not to extend MedMen’s conditional license to operate a medical marijuana dispensary in Staunton, Virginia.
U.S. Virgin Islands’ Governor Supports Marijuana Legalization
While most businesses suffered amid COVID-19, marijuana saw a drastic rise in sales. Many states have been rethinking the benefits of marijuana legalization.
Will the Abacus Health Acquisition Benefit Charlotte’s Web?
On June 11, Charlotte’s Web announced that it completed the acquisition of Abacus Health. The company’s performance wasn’t strong in the first quarter.
Curaleaf Expands Select Brand Medical Products in Connecticut
On Monday, Curaleaf Holdings announced that it will expand its Select brand products in Connecticut. The products will be available at medical dispensaries.
Illinois Reports Record Recreational Cannabis Sales in May
Illinois sold recreational cannabis worth $44.3 million in May—the highest amount since it legalized recreational sales in January this year.
Why Stifel Canada Thinks Cresco Labs Is a ‘Buy’
Cresco Labs (OTMKTS:CRLBF) started fiscal 2020 on a good note with strong first-quarter results. The company had triple-digit revenue growth.
Green Thumb Industries Opens Its 46th Retail Store
On Monday, Green Thumb Industries (OTCMKTS:GTBIF) opened a Rise brand store in Chambersburg, Pennsylvania—its 46th store in the US.
Vireo Health Terminates Bruce Linton as Its Executive Chairman
On Monday, Vireo Health announced that it terminated Bruce Linton as its executive chairman immediately. He joined the company in November 2019.
Marijuana Legalization: New Mexico Voters Show Support
In the 2020 New Mexico Democratic presidential primaries election on June 2, voters ousted most of the Senate candidates who opposed marijuana legalization.
Cresco Labs Receives Ohio Provisional Processing License
Cresco Labs (OTCMKTS:CRLBF) is trading 1.8% higher as of 9:44 AM ET today. The company received a provisional processing license by the state of Ohio.
Cannabis Market Has Good Potential in Illinois
The cannabis market in Illinois has been growing despite the COVID-19 pandemic. Illinois legalized recreational cannabis on January 1, 2020.
Marijuana Legalization Attempts in New York amid Protests
George Floyd’s death has led to mass protests in the US. Notably, social injustice was one of the main motives behind legalizing marijuana.
Cresco Labs: Analysts Revise 2020 Estimates after Earnings
Cresco Labs (OTCMKTS:CRLBF) is one of the US cannabis companies that has been consistently performing well despite the marijuana industry’s struggles.
MedMen Temporarily Closes Stores amid Protests
Amid the protests following George Floyd’s death in the US, MedMen temporarily closed all of its stores. The stock fell after the news.
Marijuana Legalization Might Bring Economic Relief in New Mexico
Governor Grisham thinks that marijuana is a good option to help New Mexico recover from the economic losses amid COVID-19.
Why Green Thumb Industries Is a Good Cannabis Bet
So far in 2020, Green Thumb Industries has returned 6.0%—one of the few cannabis companies with positive returns this year.
Will MedMen’s Q3 2020 Earnings Be a Relief?
MedMen Enterprises (OTCMKTS:MMNFF) is scheduled to report its financial results for the third quarter of fiscal 2020 on May 27 after the market closes.
Curaleaf: Analysts’ Recommendations after Its Q1 Earnings
Earlier this week, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings. The company missed analysts’ revenue expectations.
Why Did Curaleaf Report a Mixed Q1 Performance?
On Monday, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings after the market closed. The company reported revenue of $96.5 million.
Could Marijuana Legalization Help Texas Recover Its Losses?
Texas has suffered huge economic losses. Many industry experts think that marijuana legalization could be a good option to revive the state’s economy.
Why Curaleaf Is a ‘Buy’ before Its Q1 Earnings
Analysts expect Curaleaf’s EBITDA to rise during the quarter. They expect the company to report an EBITDA of $15.7 million.
Charlotte’s Web Reports Mixed Q1 Performance
Today, Charlotte’s Web reported a mixed first-quarter performance. For the quarter ended on March 31, the company reported revenues of $21.7 million.
Marijuana: Banking Access Included in Coronavirus Relief Bill
Marijuana companies in the US have been struggling to get financial and banking access. Cannabis still isn’t legal at the federal level.
New Cannabis Store Opens before Green Thumb’s Q1 Earnings
Green Thumb Industries (OTCMKTS:GTBIF) will likely report its results for the first quarter of fiscal 2020 on May 14 after the market closes.
Massachusetts Wants to Help Cannabis Businesses amid COVID-19
Massachusetts made medical cannabis essential amid the COVID-19 pandemic. However, recreational cannabis dispensaries had to shut down.
IIPR Stock Falls after Reporting Weak Q1 Performance
On May 6, Innovative Industrial Properties reported its first-quarter results after the market closed. The company posted an adjusted EPS of $0.72.
Marijuana Legalization in Nebraska Has a New Strategy
Marijuana campaigns have struggled to gather signatures amid the coronavirus pandemic. However, there’s still some hope in Nebraska.
Should You Buy IIPR before Its Q1 Earnings?
IIPR will likely report its first-quarter earnings, which ended on March 31, after the market closes on May 6. So, should you buy the stock?
Marijuana Investors: Forecast in May amid COVID-19
We still don’t know how COVID-19 will impact marijuana companies. Their sales will likely keep rising in May if lockdowns and stay-at-home orders continue.
Marijuana Legalization Sees Daylight in Lebanon, US Still Waits
Amid COVID-19, people rushed to stock up on marijuana. Lebanon is the first Middle East country to legalize medical marijuana amid the pandemic.
Cresco Labs’ Q4 Earnings: Pleasant Surprise amid COVID-19
Cresco Labs reported its results for the fourth quarter of fiscal 2019 on April 27. Analysts were hopeful about the company’s fourth-quarter earnings.
Why Is There Optimism before Cresco Labs’ Q4 Earnings?
Analysts expect Cresco Labs to report revenue of $43.7 million in the fourth quarter—YoY growth of 157.9% from $17.0 million in the fourth quarter of 2018.
Is There More Upside to Cresco Labs’ Stock Price?
Amid the weakness in the global financial markets due to the COVID-19 outbreak, Cresco Labs fell to a low of 2.81 Canadian dollars on March 17.
Analysts’ Recommendations after Charlotte’s Web’s Q4 Earnings
Charlotte’s Web Holdings reported its fourth-quarter earnings on March 24. For the quarter, the company missed analysts’ revenue and EBITDA estimates.
Analysts Cut Curaleaf’s Target Price after Its Q4 Earnings
Since Curaleaf reported its fourth-quarter earnings on March 24, Alliance Global Partners and Canaccord Genuity have lowered their target prices.
Curaleaf Reports Impressive Q4 Earnings Results
On Tuesday, Curaleaf (OTCMKTS:CURLF) reported its fourth-quarter earnings after the market closed. The company reported revenue of $75.46 million.
Will Curaleaf Beat Analysts’ Expectations in Q4?
Curaleaf Holdings (OTCMKTS:CURLF) will report its fourth-quarter earnings after the market closes on March 24. Analysts are bullish on Curaleaf.
Roth Capital Initiates Coverage on IIPR with a ‘Buy’ Rating
On March 16, Roth Capital initiated coverage on Innovative Industrial Properties (NYSE:IIPR) with a “buy” rating and a stock price of $110.
Analysts Recommend a ‘Buy’ for Curaleaf before Its Q4 Earnings
As of Thursday, nine analysts covered Curaleaf. Among the analysts, eight recommend a “buy,” while one recommends a “hold.”
IIPR Looks Promising amid Struggling Cannabis Sector
As of March 11, Innovative Industrial Properties (NYSE:IIPR) was trading at $76.96—a rise of 1.4% since the beginning of this year.
What Do Analysts Recommend for Supreme Cannabis?
Wall Street favors a “hold” rating for Supreme Cannabis. Four analysts recommend a ‘hold,’ three recommend a ‘buy,’ and one recommends a ‘sell.’
Charlotte’s Web Reports Improved Yield and CBD Potency
On Wednesday, Charlotte’s Web Holdings (NYSEARCA:CWEB) announced that the audit of its 2019 hemp harvest is complete.
How Will Curaleaf Benefit from Acquiring BlueKudu?
On Monday, Curaleaf (OTCMKTS:CURLF) announced that it will acquire BlueKudu—a company that produces premium cannabis chocolates and gummies.
Analysts Cut GW Pharmaceuticals’s Target Price after Q4 Earnings
On Tuesday, GW Pharmaceuticals reported its fourth-quarter earnings. The company reported revenue of $109.1 million, which beat analysts’ expectations.
IIPR Posts Impressive Q4 Earnings, Looks Strong in 2020
On Wednesday, IIPR reported its fourth-quarter earnings. The company reported revenues of $17.7 million, which beat analysts’ expectations of $14.4 million.
Analyzing GW Pharmaceuticals’ Q4 Earnings and Outlook
On Tuesday, GW Pharmaceuticals reported its fourth-quarter earnings after the market closed. For the quarter, the company reported revenue of $109.1 million.
What to Expect from Green Growth Brands’ Q2 Earnings?
Green Growth Brands will likely report its results for the second quarter of fiscal 2020 on February 24. Analysts expect the company’s revenue to rise sequentially.
Has Cresco Labs Bottomed Out in 2020?
As of Tuesday, Cresco Labs was trading at 6.73 Canadian dollars, which represents a fall of 24.6% since the beginning of the year.
Beacon Securities Is Still Bullish on Curaleaf
After Curaleaf completed the acquisition of the Select brand, Russell Stanley of Beacon Securities reiterated his “buy” rating.
IIPR Enters a Long-Term Agreement with GTI
Yesterday, IIPR announced that it bought a licensed cannabis processing facility in Toledo, Ohio, from Green Thumb Industries for $2.9 million.
Cresco Labs Stock Rose after Securing $100 Million Loan
On Thursday, Cresco Labs announced that it signed an agreement for a senior secured term loan for an initial aggregate principal amount of $100 million.
Is Cresco Labs a Good Bet in January?
Analysts expect Cresco Labs to report revenues of $45.3 million in the fourth quarter to take the total revenue for 2019 to $131.9 million.
Why Beacon Securities Is Bullish on Curaleaf
On Monday, Russell Stanley of Beacon Securities reiterated his “buy” rating for Curaleaf Holdings. He gave a target price of 25 Canadian dollars.
Is Charlotte’s Web Still a Good Buy?
Although 2019 was tough for Charlotte’s Web Holdings, it has made a significant recovery this year. The stock has increased by 14.8% YTD as of Monday.
GW Pharmaceuticals Provides Preliminary Sales Update
On January 12, GW Pharmaceuticals announced its preliminary unaudited product sales report for the fourth quarter and 2019.
OrganiGram’s First-Quarter Earnings: What to Expect
Yesterday, OrganiGram stock was trading at 2.68 Canadian dollars, 23.4% lower than when the company reported its fourth-quarter earnings on November 25.
TerrAscend Private Placement Oversubscribed
TerrAscend’s recent private placement was oversubscribed due to strong investor interest. It increased the offering to about $30 million from $20 million.
Why Beacon Securities Thinks Cresco Labs Is Cheap
Russell Stanley of Beacon Securities is optimistic about Cresco Labs (CRLBF) in the cannabis space. He maintained the “buy” rating and target price.
How Was 2020’s First Trading Day for Cannabis?
Yesterday, Illinois debuted the sale of adult-use cannabis. Green Thumb Industries announced that it opened its first adult-use cannabis store in the state.
Illinois Wakes Up to Legalized Recreational Cannabis
On June 25, Illinois governor J.B. Pritzker signed a bill approving marijuana use for everyone over 21 years old. The law became effective on January 1.
Cannabis Sector Rounds Out the Week in the Green
Yesterday, Ontario’s government announced that it was scrapping its cap on the number of private retail cannabis stores and moving toward a new system.
Why MedMen Stock Rose More than 24% on Thursday
The optimistic guidance and initiatives helped MedMen stock rise. On Thursday, the stock closed the day at 0.71 Canadian dollars.
Supreme Cannabis: Lower Target Price after Q1 Earnings
Following Supreme Cannabis’s weak first-quarter performance, PI Financial and Canaccord Genuity lowered their target prices.
MedMen: Price Targets and Ratings after Q1 Earnings
There have been no rating changes since MedMen reported its Q1 earnings. Six of eight analysts gave the stock a “hold” rating.
Cannabis Stocks Up despite Weak Equity Market
Despite the weakness in the broader US equity market today, the cannabis sector is trading in the green. Let’s see who’s making big moves today.
Marijuana in Hawaii: Is Further Legalization Likely?
We’ve previously discussed the varying degrees of marijuana legalization in a variety of US states. Now, let’s talk about the laws in Hawaii.
Cresco Labs: Analysts’ Ratings Post Q3 Earnings
Cresco Labs (CRLBF) (CL) reported its third-quarter earnings results after markets closed on November 26. Its stock has since fallen.
Analysts Believe the FDA Will Get Tough on CBD
Earlier this week, the FDA announced that it couldn’t conclude CBD was safe. It warned the public of various risks linked to CBD usage.
Cannabis Is Up Today: The Latest from CGC and Its Peers
The cannabis sector is in the green today. At 12:58 PM ET, the ETFMG Alternative Harvest ETF and Horizons Marijuana Life Sciences Index ETF were up 0.8%.
Cresco Labs Missed Analysts’ Q3 Estimates
Cresco Labs reported its third-quarter earnings on Tuesday after the market closed. The company missed analysts’ top-line and bottom-line estimates.
Why Cannabis Stocks Are Trending Down Today
Today, the cannabis sector was trading in the red despite the broader US equity market trading in the green. Here’s what’s going on.
Can Cresco Lab’s Q3 Earnings Drive the Cannabis Sector?
As of November 22, Cresco Labs was trading at 7.65 Canadian dollars, which implies a fall of 30% since its second-quarter earnings on August 21.
Cresco Labs’ Q3 Results Are Coming Up: What to Know
US-based vertically-integrated cannabis player Cresco Labs is set to report its fiscal 2019 third-quarter results on November 26.
Charlotte’s Web: Analysts Cut Targets after Weak Q3
Charlotte’s Web Holdings reported its fiscal 2019 third-quarter earnings results on November 13. Its revenue came in at $25.1 million.
Charlotte’s Web: Q3 Earnings Missed Analysts’ Estimates
Today, Charlotte’s Web Holdings (CWEB) (CWBHF) reported its third-quarter earnings. The company missed analysts’ revenue and EPS estimates.
Cresco Labs Kicks Off Its Incubator Program in Illinois
Cresco Labs launched its incubator program in Illinois on November 6. This program is part of Cresco’s Social Equity and Educational Development initiative.
Charlotte’s Web: Top Four Things to Know about the Stock
Last month, Charlotte’s Web announced that it would partner with Nielsen to guide US retail companies on the growth of the CBD (cannabidiol) space.
MedMen: Stock Falls over 20% after Q4 2019 Earnings
MedMen Enterprises (MMEN) (MMNFF) reported its fourth-quarter earnings that ended on June 30. The company reported revenues of $41.97 million.
Cannabis Sector in the Green despite Subdued Market
While the US markets are subdued today, with the S&P 500 and Dow Jones both down, the cannabis sector is in the green. Here’s why.
Cannabis Stocks Rise: CURLF, IIPR, ACB, WEED
After closing in the red yesterday, the US equity market was trading marginally higher today. The cannabis sector is also up—and here’s why.
Cresco Labs Stock Rises on Dispensary Approval
Yesterday, Cresco Labs (CRLBF) (CL) announced it had received licenses for its five Illinois medical cannabis dispensaries to sell adult-use cannabis.